serogroup B Neisseria meningitidis

GPTKB entity

Statements (62)
Predicate Object
gptkbp:instanceOf bacterium
gptkbp:associated_with meningitis
high morbidity
increased hospitalization rates
college outbreaks
serogroup B meningococcal disease
gptkbp:can_be long-term complications
gptkbp:causedBy meningococcal disease
gptkbp:controls vaccination
gptkbp:designatedAs pathogenic
gptkbp:diseaseResistance culture or PCR
gptkbp:divisions cerebrospinal fluid
gptkbp:has_a B
polysaccharide capsule
multiple virulence factors
gptkbp:has_a_focus_on genomic studies
infectious disease research
vaccine research
https://www.w3.org/2000/01/rdf-schema#label serogroup B Neisseria meningitidis
gptkbp:is_a Neisseria meningitidis
gptkbp:is_a_source_of bacterial meningitis
gptkbp:is_a_subject_of clinical trials
public health campaigns
gptkbp:is_accessible_by public health measures
gptkbp:is_available_in nasopharynx of healthy individuals
gptkbp:is_characterized_by high mortality rate
high genetic diversity
rapid onset of symptoms
gptkbp:is_committed_to some antibiotics
gptkbp:is_featured_in infants and young children
gptkbp:is_involved_in biofilm formation
clinical guidelines development
public health surveillance.
invasive disease
gptkbp:is_known_for antigenic variation
high rates of transmission
gptkbp:is_linked_to antimicrobial resistance
serological testing
outbreaks in close communities
serogroup B vaccine development
gptkbp:is_monitored_by health organizations
vaccine coverage rates
gptkbp:is_part_of global health initiatives
infectious disease control efforts
Neisseria genus
meningococcal surveillance programs
meningococcal vaccine development
gptkbp:is_recognized_for 1970s
gptkbp:is_studied_in epidemiology
vaccine efficacy
vaccine development strategies
pathogenesis mechanisms
gptkbp:issues public health
immunocompromised individuals
travelers to endemic areas
gptkbp:knownFor cause outbreaks in schools
evade immune response
gptkbp:leads septicemia
gptkbp:safetyFeatures respiratory droplets
gptkbp:skills certain antibiotics
gptkbp:targets monoclonal antibodies
gptkbp:worksWith antibiotics